Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis
Sign Up to like & getrecommendations! Published in 2018 at "Indian Heart Journal"
DOI: 10.1016/j.ihj.2017.10.014
Abstract: Objective Prosthetic valve thrombosis (PVT) is a dreadful complication of mechanical prosthetic valves. Thrombolytic therapy (TT) for PVT is an alternative to surgery and currently making a leading role. This study compares TT with tenecteplase… read more here.
Keywords: pvt; prosthetic valve; patients mitral; thrombolytic therapy ... See more keywords
Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase
Sign Up to like & getrecommendations! Published in 2021 at "Indian Heart Journal"
DOI: 10.1016/j.ihj.2021.02.005
Abstract: Agent of choice for thrombolytic therapy (TT) in prosthetic valve thrombosis (PVT) is unknown. 84 mitral obstructive-PVT episodes treated with TT (43: Tenecteplase; 41: Streptokinase) were included in this prospective study. The incidence of primary… read more here.
Keywords: prosthetic valve; outcomes patients; clinical outcomes; patients mitral ... See more keywords
TCT-667 Causes and Clinical Outcomes of Patients with Mitral Regurgitation Who are ineligible for Transcatheter Mitral Valve Replacement
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.1878
Abstract: Despite the increasing availability of transcatheter mitral valve replacement (TMVR) under research investigation, patients with mitral regurgitation (MR) frequently are not eligible for such therapy. The characteristics of these patients who fail qualification and their… read more here.
Keywords: transcatheter mitral; clinical outcomes; patients mitral; mitral regurgitation ... See more keywords
Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long‐term warfarin therapy
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15540
Abstract: This study aimed to develop and validate a new bleeding risk score to predict warfarin‐associated major bleeding for patients with mitral valve stenosis with atrial fibrillation (MSAF) or mechanical heart valves (MHV). read more here.
Keywords: patients mitral; valve stenosis; bleeding risk; mitral valve ... See more keywords
Myocardial Fibrosis at Cardiac MRI Helps Predict Adverse Clinical Outcome in Patients with Mitral Valve Prolapse.
Sign Up to like & getrecommendations! Published in 2022 at "Radiology"
DOI: 10.1148/radiol.220454
Abstract: Background Patients with mitral valve prolapse (MVP) may develop adverse outcomes even in the absence of mitral regurgitation or left ventricular (LV) dysfunction. Purpose To investigate the prognostic value of mitral annulus disjunction (MAD) and… read more here.
Keywords: valve prolapse; patients mitral; cardiac mri; myocardial fibrosis ... See more keywords
Mitral regurgitation and dyspnoea: the expanding role of mitral effective regurgitant orifice among un-selected patients
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cardiovascular Medicine"
DOI: 10.2459/jcm.0000000000000975
Abstract: Aims Mitral regurgitation is frequent in the general population and among suspected heart failure patients; however, to what extent it contributes to dyspnoea is unclear. We hypothesized mitral regurgitation to have a role in determining… read more here.
Keywords: regurgitation; dyspnoea; patients mitral; ero ... See more keywords
Cardiac Imaging for Risk Assessment of Malignant Ventricular Arrhythmias in Patients With Mitral Valve Prolapse
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.574446
Abstract: Recent studies have described the occurrence of complex ventricular arrhythmias and sudden cardiac death among patients with mitral valve prolapse (MVP). The reported incidence rate of sudden cardiac death or ventricular tachycardia is about 1–1.5%… read more here.
Keywords: risk; valve prolapse; patients mitral; ventricular arrhythmias ... See more keywords